» Articles » PMID: 6712002

Presence of Aminoglycoside Acetyltransferase and Plasmids in Mycobacterium Fortuitum. Lack of Correlation with Intrinsic Aminoglycoside Resistance

Overview
Specialty Pulmonary Medicine
Date 1984 Apr 1
PMID 6712002
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Isolates of the 3 biovariants of Mycobacterium fortuitum exhibited 3 patterns of resistance when tested against 9 aminoglycosides. Examination of cell lysates from the 3 groups revealed 15/15 isolates to contain an aminoglycoside acetyltransferase (AAC) resembling AAC (3)-III or (3)-IV found in bacterial species. The enzyme did not appear to confer resistance, as its activity did not correlate with any pattern of resistance. The DNA extraction revealed plasmids in only 2 of 8 isolates tested, suggesting no relationship of plasmids to intrinsic aminoglycoside resistance or the presence of the AAC. These studies, combined with current knowledge of ribosomal resistance, suggest altered cellular transport or permeability as the mechanism of intrinsic aminoglycoside resistance in this species, although the patterns of resistance are different from those observed in other bacteria with nonenzymatic aminoglycoside resistance. This is the first demonstration of specific aminoglycoside-modifying enzymes among mycobacterial species and the first report of plasmids in M. fortuitum.

Citing Articles

Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates.

Kim S, Kim D, Moon S, Song J, Huh H, Lee N Sci Rep. 2021; 11(1):6108.

PMID: 33731862 PMC: 7969740. DOI: 10.1038/s41598-021-85721-5.


Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles.

Sanz-Garcia F, Anoz-Carbonell E, Perez-Herran E, Martin C, Lucia A, Rodrigues L Front Microbiol. 2019; 10:46.

PMID: 30761098 PMC: 6363676. DOI: 10.3389/fmicb.2019.00046.


Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Brown-Elliott B, Nash K, Wallace Jr R Clin Microbiol Rev. 2012; 25(3):545-82.

PMID: 22763637 PMC: 3416486. DOI: 10.1128/CMR.05030-11.


Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?.

Ho I, Chan C, Cheng A Antimicrob Agents Chemother. 1999; 44(1):39-42.

PMID: 10602720 PMC: 89625. DOI: 10.1128/AAC.44.1.39-42.2000.


Isolation by genetic labeling of a new mycobacterial plasmid, pJAZ38, from Mycobacterium fortuitum.

Gavigan J, Ainsa J, Perez E, Otal I, Martin C J Bacteriol. 1997; 179(13):4115-22.

PMID: 9209023 PMC: 179229. DOI: 10.1128/jb.179.13.4115-4122.1997.